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  A case of recurrence of stage 1 non－seminomatous germ cell tumor of the testis （NSGCT）
8 years and IO months after orchiectomy is presented． Histology was the same for the primary
lesion and metastatic left supraclavicular lymphnodes ：’ mixed pattern of choriocarcinoma，
embryonal carcinoma， seminoma and teratoma． The patient underwent resection of the meta－
static left supraelavicu lar and retroperitoneal lymphnodes． After receiving chemotherapy
and radiotherapy postoperatively， he has been in complete re皿ission for ll months．
  It is well known that NSGaT relapses earlier than seminoma， and that most of the recur－
rences of stage I NSGCT occur within 24 months aftcr treat皿ent． Recently some investiga．
tors stress the importance of close follow－up of stage I NSGCT with（〕T scan and tu皿or
markers for a period of 2 years without adjuvant chemotherapy or radiotherapy． But analysis
on recurrencc patterns shows that thc recurrent disease， probably regardless of the ti皿e of its
onset， progresses rapidiy and systema亡ically， and that亡he prognosis of advanced testicuユar tumors
is poor even with intensive therapy． lt is eur conc・lusion that the period of close followup
should be longer than generally accepted so that late recurrence can be detected at its onset．．
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〔初診時検査所見〕 血算＝RBC 480 x 104／mm3，
Hb 15．3 g／dl Ht 44．5％， WBC 7，100／mm3， Plt 25．1
×lo4，血液化学lT． P．7．6 g／dl， Alb 4．99／d1， Al－P
991U／t， LDH 2161UII， GOT 131UII， GPT 12
1U／1， gamma－GTP 21 IUII， T－Bil O．9 mg／dl， Cho1
171mg／dl， UN 11mg／dl， Cr 1．2 mg／dl， Na 141
mEq！1， K 3．8 mEq／1， Cl 104 mEq／1， Ca 4．6 mEq／1，
P 8．5mg／dl， ESR： 6 mm／h， Serum hCG： 668．O




































Fig． 1． Teratomatous e，lement of the right testis tumor
Fig． 2． Choriocarcinomatous elernent of the tumor
   A syncytiotrophoblastic cell is on the lower left
Fig． 3． Embryonal carcinomatous element of the tumor
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論難 Fig． 5 Swelling of retroperitoneal lymphnode
  （low density area） Just adjacent to in－
  ferlor vena cava
Fig． 4． Left supraclavicular mass
  of a hen－egg size
 Fig 6 Teratomatous element of the left supraclavicular metastasis
Fig． 7． Mixed element of the left supraclavicular metastasis

























































Fig． 9． Bizarre large cells and ghost cells in the
    retroperitoneal lymphnode resected after
    chemotherapy
Fig． 8． Metastatic retroperitoneal
    lymphnode． lnferior vena
    cava is retracted left
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  12345678 9 10 ll 12 ’821Serum hCGIbeta－hCG before and during Treatment
We have changed to monitor beta－hCG since August ’81． Sharp decline of beta－hCG








短い． またstage Iのmalignant teratoma，









































































と mixed pattern （germ cell tumors showing
more than one histological pattern）に属し，その
elementはchoriocarcinoma（Cと略す．以下同じ），










 Stage I NSGGTの再発部位についてBabaian
ら17）はその67－81％は肺であると述べている．Gilbert


















隔リンパ節再発を認めたstage I NSGCT 5例全例
がextr n。dal metastascsを有し，1例は後腹膜リ
ンパ節再発をも有していたと報告している．
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